|
| |
Overview
Financial Highlight
HeadlinesBusiness Background TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women’s clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
  money888 results will be better and better only....with new wing opening, more bed capacity, more revenue and profit 10/02/2022 1:09 PM BursaRangers https://klse.i3investor.com/blogs/BursaRangersTechnicalPicks/2022-02-27-story-h1599320991-BursaRangers_Daily_Technical_Picks_28_February_2022.jsp 28/02/2022 12:23 AM Kitty Kitty New wing started to contribute to the financial result. As time goes, significant improvement will show very soon. 24/08/2022 7:14 AM comebackkid Less men more share then? Contrarian approach? Perhaps another takeover target. 13/12/2023 11:10 PM newbird33 Bot enough, start to promote. https://klse.i3investor.com/web/blog/detail/sinchew_company_story/2024-01-01-story-h-211423465 01/01/2024 10:51 PM sherlock Alpha IVF listing with RM1.5 billion valuation soon,i think TMC was very much undervalued at current price. 02/03/2024 1:13 AM sherlock Beside IVF business which is recovering strongly,TMC also owned Thomson Hospital Kota Damansara,a premium hospital with 336 operating bed currently and maximum capacity of 554 bed when fully utilized the new wing by 2026. 02/03/2024 1:22 AM sherlock my personal opinion, TMC should worth around RM2 .0 to 2.4 billion based on FY2024 EV/Ebitda of 18-20x，the target valuation consider quite conservative given the rapid capacity expansion and high growth potential in next 5 year. 02/03/2024 1:31 AM Up_down Price did not react much to the 2nd letter to the suspended CEO. It looks good. 07/05/2024 1:14 PM Up_down With the existing 314 medical beds, the hospital segment generated RM 82 million in a quarter. TMC would increase quantity of bed to 394 (in Kota Damansara) by Jun 2024. Expect revenue up by RM 20 million per quarter for extra 80 beds. 23/05/2024 12:20 PM Up_down Potential of leap in revenue growth until 2027 with the medical beds capacity 554 units. TMC has added 80 medical bed in 2024 and follow by 80 units each for year 2025 and 2026. 23/05/2024 12:33 PM Kitty Kitty According tot the annual report, it will only commence construction after RTS starts running 13/06/2024 2:45 PM newbird33 展望下半年，目前马股可谓利好环绕，获经济展望强稳、企业获利复苏、资金回流等因素加持，交投料保持活络，可望延续上半年强势。选股方面，笔者相对看好消费、建筑及科技股，整体料在利好加持下表现可期。 配合半年检讨，笔者决定对神通科技（SCOMNET,0001,创业板医疗保健组）和优宾机构（EUPE,6815,主机板产业组）进行套利，同时对TMC生命科学（TMCLIFE,0101,主机板医疗保健组）停损。 01/07/2024 11:20 AM M55555 Ann. Date Ex Date Type Subject Amount 21-Aug-2024 05-Dec-2024 DIVIDEND Special Dividend RM 0.0172 21-Aug-2024 05-Dec-2024 DIVIDEND Final Dividend RM 0.0048 The Board of Directors of the Company is proposing a single-tier final dividend of 0.4898 sen per ordinary share and a special single-tier dividend of 1.7271 sen per ordinary share for the financial year ended 30 June 2024 subject to the shareholders' approval at the forthcoming Twenty-Second Annual General Meeting of the Company. This announcement is dated 21 August 2024. 21/08/2024 9:34 PM  | | ||||||||||||||||||||||||||||||||||||||||||||||||
